Niepomniszcze H, Coleoni A H, Targovnik H M, Iorcansky S, Degrossi O J
Acta Endocrinol (Copenh). 1980 Jan;93(1):25-31. doi: 10.1530/acta.0.0930025.
A 16-year-old male cretin with congenital goitrous hypothyroidism and 95% discharge in the perchlorate test underwent thyroidectomy. Thyroid studies disclosed negligible peroxidase (TPO) activity in the tyrosine iodinase assay, 6 nmoles I- inc./g (normals: 220-410). Using the same particulate preparations, a high activity was obtained in the guaiacol assay, 485 U/mg vs. 176 U/mg of a control gland. Goitre TPO was solubilized by treating the thyroid pellets with deoxycholate, trypsin and acetone. Soluble goitre TPO was further purified on Sephadex G-200. By this procedure we obtained a single peak of enzyme activity for oxidizing guaiacol, although no activity was found for iodinating tyrosine. I2 formation, as measured by the triiodide assay, was only 28% of that expected for normal TPO when compared for guaiacol oxidation. It is concluded that this abnormal TPO was the cause of the congenital hypothyroidism of the patient. We suggest the term "thyroid peroxidase-iodinase defect" for defining this newly found inborn error.
一名患有先天性甲状腺肿性甲状腺功能减退症的16岁男性克汀病患者,在过氯酸盐试验中有95%的释放率,接受了甲状腺切除术。甲状腺研究显示,在酪氨酸碘化酶测定中,过氧化物酶(TPO)活性可忽略不计,为6纳摩尔碘摄入/克(正常范围:220 - 410)。使用相同的微粒制剂,在愈创木酚测定中获得了高活性,为485 U/mg,而对照腺体为176 U/mg。通过用脱氧胆酸盐、胰蛋白酶和丙酮处理甲状腺颗粒,使甲状腺肿TPO溶解。可溶性甲状腺肿TPO在Sephadex G - 200上进一步纯化。通过该程序,我们获得了一个氧化愈创木酚的单一酶活性峰,尽管在碘化酪氨酸方面未发现活性。通过三碘化物测定法测量,与愈创木酚氧化相比,碘形成仅为正常TPO预期值的28%。结论是这种异常TPO是患者先天性甲状腺功能减退症的原因。我们建议用“甲状腺过氧化物酶 - 碘化酶缺陷”这一术语来定义这种新发现的先天性疾病。